Moderate to Severe Atopic Dermatitis Clinical Trial
Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.
Study Overview
- Ages: 18 to 65 are eligible
Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost - Study Duration: 9 clinic visits over 6 months
- Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis
